FDA Approves First Over-the-Counter Combination Pain Reliever
The FDA has approved a new over-the-counter pain reliever, Tylenol with Naproxen, which combines acetaminophen and naproxen sodium for 12-hour relief. This marks the first time these two medications have been combined in a single fixed-dose product available without a…
Portland, OR, July 30, 2026 — The U.S. Food and Drug Administration (FDA) has authorized a new over-the-counter pain relief medication, Tylenol with Naproxen. This product is notable as it represents the first instance of acetaminophen and naproxen sodium being combined into a single, fixed-dose product accessible to consumers without a prescription.
Tylenol with Naproxen is formulated to provide relief from pain for up to 12 hours. The combination aims to offer consumers a new option for managing various types of pain through readily available medication.
Acetaminophen, commonly known as Tylenol, and naproxen sodium, found in products like Aleve, are both established pain relievers. However, until this approval, consumers seeking the benefits of both ingredients typically had to purchase and manage them as separate medications. This new combination product simplifies the pain management regimen for individuals who previously used both active ingredients.
The FDA’s approval signifies that the agency has reviewed the safety and efficacy data for this specific combination and determined it to be suitable for over-the-counter use. The availability of Tylenol with Naproxen is expected to provide a convenient alternative for pain management for a wide range of consumers.
Story summarized from the original created by Dallas Gagnon on www.oregonlive.com, see more information here.
